Skip to main content
main-content

Pediatric rheumatology

Medications

14-12-2018 | Pediatric | Article

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review

Jung JY et al. Pediatr Rheumatol 2018; 16: 79. doi: 10.1186/s12969-018-0296-z

26-11-2018 | Juvenile idiopathic arthritis | News

Disease subtype, treatment choice may impact infection risk in JIA patients

Among biologic-treated patients with juvenile idiopathic arthritis, infection risk may differ according to disease subtype and the biologic agent used, researchers report.

Source:

Clin Rheumatol 2018; doi:10.1007/s10067-018-4367-9

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

18-10-2018 | Infection | Editorial | Article

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

Author:
NM Wulffraat, AM de Groot, EES Nieuwenhuis

15-10-2018 | Juvenile idiopathic arthritis | News

Response to canakinumab sustained for up to 5 years in children with sJIA

Response to canakinumab therapy is sustained or even improved for up to 5 years in children with systemic juvenile idiopathic arthritis, with no new safety signals, according to the results of a long-term extension study published in the Annals of the Rheumatic Diseases.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213150

01-10-2018 | Juvenile idiopathic arthritis | Review | Article

Glucocorticoid treatment in juvenile idiopathic arthritis

Batu ED. Rheumatol Int 2018. doi: 10.1007/s00296-018-4168-0

Increased risk for preterm delivery in women with RA and JIA

Women with rheumatoid arthritis and those with juvenile idiopathic arthritis have a significantly elevated risk for preterm delivery, according to a prospective cohort study published in Arthritis Care & Research.

06-09-2018 | Pregnancy | Highlight | News

Increased risk for preterm delivery in women with RA and JIA

Women with rheumatoid arthritis and those with juvenile idiopathic arthritis have a significantly elevated risk for preterm delivery, according to a prospective cohort study published in Arthritis Care & Research.

Source:

Arthritis Care Res 2018; doi:10.1002/acr.23730

21-08-2018 | Juvenile idiopathic arthritis | Article

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

Kearsley-Fleet L et al. Rheumatology (Oxford) 2018: key262. doi: 10.1093/rheumatology/key262

02-08-2018 | Juvenile idiopathic arthritis | News

Support for early initiation of biologics in patients with severe JIA

Study results indicate that patients with severe juvenile idiopathic arthritis who start biologic DMARDs within 2 years of symptom onset have better long-term outcomes than those who begin treatment later.

Source:

Arthritis Care Res 2018; doi:10.1002/acr.23709

17-07-2018 | Adalimumab biosimilar | News

approvalsWatch

EMA backs new adalimumab biosimilar

Click through for more information on this decision

16-07-2018 | Pregnancy | Highlight | News

TNF inhibitor discontinuation during pregnancy associated with increased flare risk

Women with inflammatory arthritis who discontinue tumor necrosis factor inhibitor therapy during pregnancy may be at increased risk for flare, researchers report.

Source:

J Rheumatol 2018; doi:10.3899/jrheum.171152

11-07-2018 | Juvenile idiopathic arthritis | Review | Article

Methotrexate in juvenile idiopathic arthritis: Advice and recommendations from the MARAJIA expert consensus meeting

Ferrara G et al. Pediatr Rheumatol 2018; 16: 46. doi: 10.1186/s12969-018-0255-8

11-07-2018 | Pediatric | Review | Article

Pediatric Rheumatology Collaborative Study Group: Over four decades of pivotal clinical drug research in pediatric rheumatology

Brunner HI et al. Pediatr Rheumatol 2018; 16: 45. doi: 10.1186/s12969-018-0261-x

01-07-2018 | Pregnancy | Article

Maternal and fetal outcomes in a cohort of patients exposed to tumor necrosis factor inhibitors throughout pregnancy

Genest G, Spitzer KA, Laskin CA. J Rheumatol 2018. doi: 10.3899/jrheum.171152

image credits